Screening compound: C20H21ClN2O3S (D512-0189)

Screening compound: C<sub>20</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>3</sub>S (D512-0189)
Screening compound: C<sub>20</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>3</sub>S (D512-0189) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C20H21ClN2O3S (D512-0189)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D512-0189

Molecular Formula

C20H21ClN2O3S (C20 H21 ClN2 O3 S)

Compound Name

(4aR,7aS)-1-(3-chlorophenyl)-4-(4-methylbenzyl)hexahydro-1H-6lambda~6~-thieno[3,4-b]pyrazine-2,6,6-trione

IUPAC name

(4aR7aS)-1-(3-chlorophenyl)-4-[(4-methylphenyl)methyl]-octahydro-6lambda6-thieno[34-b]pyrazine-266-trione

SMILES

Cc1ccc(CN(CC2=O)[C@H](CS(C3)(=O)=O)[C@H]3N2c2cccc(Cl)c2)cc1

InChI

InChI=1S/C20H21ClN2O3S/c1-14-5-7-15(8-6-14)10-22-11-20(24)23(17-4-2-3-16(21)9-17)19-13-27(25,26)12-18(19)22/h2-9,18-19H,10-13H2,1H3/t18-,19-/m0/s1

InChI Key

NDWOUUPCZRUJST-OALUTQOASA-N

MDL Number (MFCD)

C20H21ClN2O3S (D512-0189) in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Anti-Aging Library (44940 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Epigenetics Focused Set (26518 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with C20H21ClN2O3S (D512-0189) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C20H21ClN2O3S (D512-0189)?
Check Price and Availability of C20H21ClN2O3S (D512-0189), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C20H21ClN2O3S (D512-0189) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C20H21ClN2O3S (D512-0189)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C20H21ClN2O3S (D512-0189)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C20H21ClN2O3S (D512-0189) available by request